Measuring the Impact of Data Quality and Computable Phenotypes on Potential Racial Disparities in Predicting Healthcare Utilization Among Type 2 Diabetes Populations
摘要
Type 2 diabetes (T2D) computable phenotypes identify different denominator populations for downstream tasks. Differences in racial composition could introduce bias and lead to disparate disease management. The objective of this study was to assess potential racial disparities in predicting T2D healthcare utilization introduced by data quality and computable phenotypes.
MethodsFour published and one local T2D phenotypes were applied to the EHR and claims datasets of a large academic medical center. Population characteristics were compared across phenotypes, stratified by race. We induced data incompleteness, inaccuracy, and untimeliness to measure the impact on denominator racial composition. We trained logistic classification models on each of the phenotype-specific populations separately and compared disparities in utilization prediction (i.e., inpatients (IP) and emergency room (ER) admissions). Model performance, such as mean AUC and positive/negative predictive values, were compared across phenotypes, stratified by race.
ResultsDifferent T2D computable phenotypes identified populations with modestly different racial compositions. Black T2D patients had the highest average admissions to ER compared to other racial groups. Induced data quality challenges diminished patient counts across all racial groups proportionally. Charlson comorbidity score had the highest odds ratio in predicting IP and ER admissions across phenotypes and race groups. Specific T2D phenotypes showed the highest and lowest mean AUCs in predicting IP and ER admissions in Black and White populations; however, such results were not observed among Asian/Other populations.
ConclusionUtilization prediction differed among phenotypes and race groups. Understanding the complexities behind phenotypes, data quality, and predictive models could mitigate health disparity further downstream and inform clinical research and disease management.